Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06057610
What this trial is testing

A Phase III Study of SHR-A1811 Injection With or Without Pertuzumab in HER2-Positive Recurrent or Metastatic Breast Cancer

Who this might be right for
HER2-PositiveRecurrent or Metastatic Breast Cancer
Jiangsu HengRui Medicine Co., Ltd. 868
Not applicableStudy completedNCT00248547
What this trial is testing

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

Who this might be right for
Cancer
OHSU Knight Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT02187991
What this trial is testing

Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer

Who this might be right for
Breast CancerBreast CarcinomaBreast Tumors+1 more
US Oncology Research 169
Early research (Phase 1)Study completedNCT01816035
What this trial is testing

Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by Surgery

Who this might be right for
HER2/Neu PositiveRecurrent Breast CarcinomaStage IIIB Breast Cancer+2 more
University of Washington 13
Testing effectiveness (Phase 2)Study completedNCT00077376
What this trial is testing

Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerRecurrent Breast Cancer+1 more
National Cancer Institute (NCI) 61
Testing effectiveness (Phase 2)Ended earlyNCT03435640
What this trial is testing

REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies

Who this might be right for
MelanomaMerkel Cell CarcinomaTriple Negative Breast Cancer+4 more
Nektar Therapeutics 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT00609791
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 40
Early research (Phase 1)Ended earlyNCT01149356
What this trial is testing

RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+4 more
National Cancer Institute (NCI) 15
Not applicableEnded earlyNCT00503841
What this trial is testing

Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Barbara Ann Karmanos Cancer Institute 44
Testing effectiveness (Phase 2)Study completedNCT01204242
What this trial is testing

IRB-HSR# 13957: IV Lidocaine for Patients Undergoing Primary Breast Cancer Surgery:

Who this might be right for
Breast Cancer
University of Virginia 78
Large-scale testing (Phase 3)Active Not RecruitingNCT01953588
What this trial is testing

Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerInvasive Ductal Breast Carcinoma+6 more
Alliance for Clinical Trials in Oncology 1,473
Early research (Phase 1)Study completedNCT00003761
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)WithdrawnNCT00054470
What this trial is testing

Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
The University of Texas Health Science Center at San Antonio
Large-scale testing (Phase 3)UnknownNCT06857305
What this trial is testing

Efficacy and Safety of Biweekly Regimen of Eribulin Versus a Standard Regimen for the Treatment of Locally Recurrent or Metastatic HER2-negative Breast Cancer: a Multicenter, Randomized, Open-label, Phase III Trial

Who this might be right for
Breast Cancer Metastatic
Ma Fei，MD 192
Early research (Phase 1)Study completedNCT02623751
What this trial is testing

Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer

Who this might be right for
Breast Cancer
Kyowa Kirin Co., Ltd. 15
Not applicableUnknownNCT02688725
What this trial is testing

Post-Mastectomy Surveillance to Detect Recurrence in Breast Cancer Patients

Who this might be right for
Breast Cancer
Providence Health & Services 100
Not applicableStudy completedNCT03109990
What this trial is testing

A Pilot Study to Evaluate the Impact of Dexmedetomidine on Breast Cancer Recurrence After Surgery

Who this might be right for
Breast Cancer
RenJi Hospital 148
Not applicableUnknownNCT01420185
What this trial is testing

Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,300
Testing effectiveness (Phase 2)Study completedNCT00012025
What this trial is testing

ICI 182780 in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 80
Not applicableWithdrawnNCT03941223
What this trial is testing

Regional Anesthesia for Breast Surgery

Who this might be right for
Breast Cancer
Azienda USL Reggio Emilia - IRCCS
Next Page